compounded semaglutide shortage Novo Nordisk's officially concludes in the US, spelling major threat for weight loss drug compounders GLP-1 Shortage = Over -

Honest Care currently focuses on GLP-1 medications, including Zepbound, Wegovy, Mounjaro, and Ozempic

Thats why we offer advanced weight management options such as Semaglutide GLP-1, a medication belonging to a class called GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists)

Doctors typically follow a the drugs recommended titration schedule

no combo data CagriSema (Cag + Sema) NDA under FDA review Retatrutide Alone Phase 3 ongoing Feature Estimated grey-market cost Cagrilintide + Retatrutide $600-$1,200/month CagriSema (Cag + Sema) $500-$900/month Retatrutide Alone $300-$600/month Cost ranges reflect typical research-grade pricing across COA-verified suppliers as of June 2026 - verify supplier pricing before ordering

Result Confirmed the Phase 2 efficacy pattern: significant weight loss at both 0.25 mg and 0.5 mg compared to placebo, with about 10% mean weight loss at the higher dose over 24 weeks